자동 조제 기기 시장 보고서(2026년)
Automated Compounding Devices Global Market Report 2026
상품코드 : 1939306
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,777,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,796,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,815,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

자동 조제 기기 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 25억 1,000만 달러에서 2026년에는 26억 9,000만 달러로, CAGR 7.1%로 확대가 전망되고 있습니다. 지난 수년간의 성장 요인은 병원 약국의 업무량 증가, 무균 정맥내 제제 수요 증가, TPN 조제 자동화 조기 도입, 조제 오류 감소를 위한 병원들의 노력, 입원 환자 대상 약물 치료량 확대 등이 꼽히고 있습니다.

자동 조제 기기 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 35억 3,000만 달러에 달하며, CAGR은 7.0%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 약물 안전 컴플라이언스에 대한 관심 증가, 자동화 약국 기술에 대한 투자 증가, 무균 조제 서비스 아웃소싱 확대, 종양학 및 집중치료제 조제 확대, 디지털 워크플로우 및 보고 시스템 통합 진전 등이 꼽힙니다. 예측 기간 중 주요 동향으로는 병원 및 약국 환경에서 수작업으로 인한 약품 조제 오류를 줄이기 위한 자동 조제 기기 도입 증가, 정맥주사제, 항암제, TPN 용액에 대한 고정밀 조제 수요 증가, 헬스케어 시스템에서 중앙집중식 대용량 무균 조제 시설로의 전환 확대, 조제 프로세스에서 자동화된 워크플로우 검증 및 바코드 기반 검증의 활용 확대, 약국 업무를 위한 컴팩트하고 모듈식이며 업그레이드가 가능한 자동 조제 플랫폼에 대한 선호도 증가 등을 들 수 있습니다.

개인 맞춤형 헬스케어의 보급 확대는 향후 자동조제기기 시장 확대를 견인할 것으로 예측됩니다. 맞춤형 의료는 각 환자의 고유한 특성에 맞게 의료 결정, 관행, 개입, 치료를 조정하는 것을 말합니다. 맞춤형 의료 증가는 유전학의 발전, 환자별 데이터, 규제적 지원 등에 기인합니다. 자동조제장치(ACD)는 환자 개개인의 요구에 맞는 맞춤형 약품 조제를 정밀하고 정확하게 할 수 있으므로 개인맞춤형 헬스케어에서 매우 중요합니다. 이 장비는 다양한 의약품 성분을 정확한 비율로 혼합하는 과정을 자동화하여 개인 맞춤형 치료제를 만드는 데 필수적입니다. 예를 들어 미국 비영리단체인 '맞춤의료연합'에 따르면 2024년 2월 현재 FDA는 2023년 희귀질환에 대한 16건의 새로운 맞춤치료제를 승인했습니다. 이는 2022년 6건에서 증가한 수치입니다. 이처럼 맞춤형 의료의 부상은 자동조제장치 시장의 성장을 가속하고 있습니다.

자동조제장치 시장에서 사업을 운영하는 주요 기업은 AI를 탑재한 로봇 조제 솔루션을 통한 기술 혁신을 중시하고 있습니다. 여기에는 인공지능, 중량 측정을 통한 검증, 클라우드 기반 모니터링을 활용하여 고정밀 무균 혼합 조제 자동화, 실시간 품질 검증, 지속적인 모니터링을 실현하는 AI 기반 정맥내 조제 플랫폼 시스템이 포함됩니다. 예를 들어 2025년 8월, 미국에 본사를 둔 의료 기술 기업 옴니셀(Omnicell)은 약물 조제의 안전성과 정확성을 향상시키기 위해 AI 기반 정맥내 조제 시스템 업그레이드를 발표했습니다. 이 강화된 시스템에는 조제 과정을 지속적으로 모니터링하고 표준 절차에서 벗어난 부분을 자동으로 식별하고 경고하는 고급 AI 기반 품질 보증 기능이 내장되어 있습니다. 옴니셀은 이러한 첨단 자동화된 모니터링 수준을 통해 인적 오류를 최소화하고 워크플로우의 효율성을 최적화하여 약국 업무에서 높은 수준의 의약품 품질을 유지하는 것을 목표로 하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

Automated compounding devices are specialized pieces of equipment designed to automate the preparation of medications, including intravenous (IV) solutions, in healthcare settings. These devices ensure precise and efficient compounding, thereby enhancing patient safety and minimizing the risk of human error in medication preparation.

The main components of automated compounding devices include equipment and software. The equipment encompasses the physical parts of the devices used for automated medication preparation, such as robotic arms, dispensing units, and mixing chambers, which are crucial for the mechanical and physical operations that automate the compounding process, ensuring accuracy and efficiency. Product types are categorized into intravenous compounding systems, oral compounding systems, and total parenteral nutrition (TPN) compounding systems. The mode of operation includes fully automated and semi-automated compounding systems. End-users of these devices include hospitals, ambulatory surgical centers, and other healthcare facilities.

Tariffs are influencing the automated compounding devices market by increasing the cost of precision pumps, electromechanical dispensing units, stainless-steel components, and electronic control modules sourced across international supply chains, leading to higher capital and maintenance costs for hospitals and ambulatory centers. The most affected segments include fully automated and tpn compounding systems in regions dependent on imported hardware assemblies, particularly in North America, Europe, and parts of Asia-Pacific. However, tariffs are also encouraging localized manufacturing, supplier diversification, and regional software-hardware integration initiatives, which may help reduce long-term dependency on foreign component sourcing.

The automated compounding devices market research report is one of a series of new reports from The Business Research Company that provides automated compounding devices market statistics, including automated compounding devices industry global market size, regional shares, competitors with a automated compounding devices market share, detailed automated compounding devices market segments, market trends and opportunities, and any further data you may need to thrive in the automated compounding devices industry. This automated compounding devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The automated compounding devices market size has grown strongly in recent years. It will grow from $2.51 billion in 2025 to $2.69 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing hospital pharmacy workload, rising demand for sterile iv preparation, early adoption of tpn compounding automation, hospital initiatives to reduce compounding errors, expansion of inpatient medication therapy volumes.

The automated compounding devices market size is expected to see strong growth in the next few years. It will grow to $3.53 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to growing emphasis on medication safety compliance, rising investments in automated pharmacy technology, increasing outsourcing of sterile compounding services, expansion of oncology and critical care drug compounding, growing integration of digital workflow and reporting systems. Major trends in the forecast period include increasing adoption of automated compounding devices to reduce manual medication preparation errors in hospital and pharmacy settings, rising demand for high-precision compounding of iv formulations, oncology drugs, and tpn solutions, growing shift toward centralized and large-volume sterile compounding facilities in healthcare systems, expanding use of automated workflow validation and barcode-based verification in compounding processes, increasing preference for compact, modular, and upgradeable automated compounding platforms for pharmacy operations.

The growing prevalence of personalized medicines is expected to drive the expansion of the automated compounding devices market in the future. Personalized medicine involves tailoring healthcare decisions, practices, interventions, and treatments to the unique characteristics of each patient. This increase in personalized medicines is attributed to advances in genetics, patient-specific data, and regulatory support. Automated compounding devices (ACDs) are vital in personalized medicine, as they enable the precise and accurate preparation of custom medication formulations tailored to individual patient needs. These devices automate the process of mixing various pharmaceutical ingredients in exact proportions, which is essential for creating personalized treatments. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. Thus, the rise in personalized medicines is fueling the growth of the automated compounding devices market.

Major companies operating in the automated compounding devices market are emphasizing technological advancement through AI-powered robotic compounding solutions, including AI-enabled IV compounding platform systems that leverage artificial intelligence, gravimetric verification, and cloud-based monitoring to automate sterile admixture preparation with high accuracy, real-time quality validation, and continuous supervision. For example, in August 2025, Omnicell, a U.S.-based health technology company, introduced an AI-driven upgrade to its IV compounding system aimed at enhancing safety and precision in medication preparation. The enhanced system incorporates sophisticated AI-based quality assurance capabilities that continuously oversee compounding processes and automatically identify and flag deviations from standard procedures. Through this advanced level of automated monitoring, Omnicell seeks to minimize human error, optimize workflow efficiency, and uphold elevated standards of medication quality within pharmacy operations.

In October 2024, Biovalley Investments & Partners S.p.A. (BIP), an Italy-based healthcare-focused industrial investment and pharma-automation company, entered into a partnership with Engmotion d.o.o. to jointly develop and industrialize the ChemoMaker automated IV chemotherapy compounding system. Through this collaboration, Biovalley and Engmotion seek to introduce a compact, hospital-ready hazardous IV compounding solution that automates the preparation of patient-specific chemotherapy doses within existing laminar flow hoods, enhancing accuracy, sterility, operator safety, and drug utilization while providing a more accessible alternative to large, high-cost IV robotic compounding systems. Engmotion d.o.o. is a Slovenia-based company specializing in high-precision automated filling and compounding systems for syringes, vials, cytostatics, and antibiotics used in medical and pharmaceutical applications.

Major companies operating in the automated compounding devices market are Becton Dickinson and Company, Baxter International Inc, B Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Fagron NV, Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group SPA, ARxIUM Inc., Codonics Inc., Equashield LLC, Yuyama Mfg Co Ltd, Shanghai Weibond Technology Co Ltd, Medimpex LLC, Medica Inc

North America was the largest region in the automated compounding devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the automated compounding devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The automated compounding devices market consists of closed-system transfer devices, automated oral solid dose dispensers, and dispensing cabinets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Automated Compounding Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses automated compounding devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for automated compounding devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated compounding devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Automated Compounding Devices Market Characteristics

3. Automated Compounding Devices Market Supply Chain Analysis

4. Global Automated Compounding Devices Market Trends And Strategies

5. Automated Compounding Devices Market Analysis Of End Use Industries

6. Automated Compounding Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Automated Compounding Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Automated Compounding Devices Total Addressable Market (TAM) Analysis for the Market

9. Automated Compounding Devices Market Segmentation

10. Automated Compounding Devices Market Regional And Country Analysis

11. Asia-Pacific Automated Compounding Devices Market

12. China Automated Compounding Devices Market

13. India Automated Compounding Devices Market

14. Japan Automated Compounding Devices Market

15. Australia Automated Compounding Devices Market

16. Indonesia Automated Compounding Devices Market

17. South Korea Automated Compounding Devices Market

18. Taiwan Automated Compounding Devices Market

19. South East Asia Automated Compounding Devices Market

20. Western Europe Automated Compounding Devices Market

21. UK Automated Compounding Devices Market

22. Germany Automated Compounding Devices Market

23. France Automated Compounding Devices Market

24. Italy Automated Compounding Devices Market

25. Spain Automated Compounding Devices Market

26. Eastern Europe Automated Compounding Devices Market

27. Russia Automated Compounding Devices Market

28. North America Automated Compounding Devices Market

29. USA Automated Compounding Devices Market

30. Canada Automated Compounding Devices Market

31. South America Automated Compounding Devices Market

32. Brazil Automated Compounding Devices Market

33. Middle East Automated Compounding Devices Market

34. Africa Automated Compounding Devices Market

35. Automated Compounding Devices Market Regulatory and Investment Landscape

36. Automated Compounding Devices Market Competitive Landscape And Company Profiles

37. Automated Compounding Devices Market Other Major And Innovative Companies

38. Global Automated Compounding Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Automated Compounding Devices Market

40. Automated Compounding Devices Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기